Blockage of TGF-β pathway in ILCs disrupts ILCreg transdifferentiation and inhibits tumor growth, detecting an increased number of ILC3s in the tumor (30) (Figure s 1A, B). The gene discussed is TGFB1; the disease is neoplasm.